The present specification provides novel analogs of khellin, a natural product, which are useful in the treatment and prevention of atherosclerosis. Particularly, the present disclosure provides novel 5H-furo[3,2-g]-benzopyran-5-one substituted at the four and nine positions by methoxy or optionally substituted at the four position by hydroxy or alkoxy groups other than methoxy, certain 7-(N,N-dialkylaminoethen-2-yl substituted compounds. Also provided are certain novel antiatherosclerotic 7H-furo[3,2-g][1]benzopyrans.
本规范提供了khellin的新型类似物,其可用于动脉粥样硬化的治疗和预防。特别地,本文披露了在四位和九位被甲氧基取代或在四位被羟基或甲氧基以外的烷氧基等取代基替换的新型5H-
呋喃[3,2-g]-苯并
吡喃-5-酮,以及某些7-(N,N-二烷基
氨基
乙烯-2-基)取代化合物。此外,还提供了某些新型抗动脉粥样硬化的7H-
呋喃[3,2-g][1]苯并
吡喃。